Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia

Up to one-third of those with schizophrenia fail to respond to standard antipsychotics and are considered to have treatment-resistant schizophrenia, a condition for which clozapine is the only evidence-based medication. While up to 60% of treated individuals obtain therapeutic benefits from clozapin...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pharmacol
Главные авторы: Willcocks, Isabella R., Legge, Sophie E., Nalmpanti, Mariana, Mazzeo, Lucy, King, Adrian, Jansen, John, Helthuis, Marinka, Owen, Michael J., O’Donovan, Michael C., Walters, James T. R., Pardiñas, Antonio F.
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094024/
https://ncbi.nlm.nih.gov/pubmed/33959025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.658734
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы